Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Cheung

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Environmental Research and Public Health|July 9, 2022
Epithelial Ovarian Cancer: Providing Evidence of Predisposition GenesSidrah Shah, Alison Cheung, Mikolaj Kutka, et al.
Orbit (Amsterdam, Netherlands)|July 29, 2021
Three-dimensional reconstruction of the orbital retrobulbar vasculatureDominic X Texeira, Alison Cheung, Hasan Naveed, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Non-Epithelial Ovarian Cancers: How Much Do We Really Know?Alison Cheung, Sidrah Shah, Jack Parker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2002
Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic responseMelissa T Jack, Richard A Woo, Atsushi Hirao, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 7, 2024
A Modified Bleaching Method for Multiplex Immunofluorescence Staining of FFPE Tissue SectionsDan Wang, Alison Cheung, Gordon E Mawdsley, et al.
The Canadian Journal of Hospital Pharmacy|March 14, 2024
Clinical Pharmacy Services in Canadian Emergency Departments: A 2022 National SurveyRichard Wanbon, Eric Villeneuve, Olena Serwylo, et al.
Molecular and Cellular Biology|August 23, 2002
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent mannerAtsushi Hirao, Alison Cheung, Gordon Duncan, et al.
Cancer Research|October 29, 2021
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune ResponseNisha Kanwar, Zaldy Balde, Ranju Nair, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Environmental Research and Public Health|July 9, 2022
Epithelial Ovarian Cancer: Providing Evidence of Predisposition GenesSidrah Shah, Alison Cheung, Mikolaj Kutka, et al.
Orbit (Amsterdam, Netherlands)|July 29, 2021
Three-dimensional reconstruction of the orbital retrobulbar vasculatureDominic X Texeira, Alison Cheung, Hasan Naveed, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Non-Epithelial Ovarian Cancers: How Much Do We Really Know?Alison Cheung, Sidrah Shah, Jack Parker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2002
Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic responseMelissa T Jack, Richard A Woo, Atsushi Hirao, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 7, 2024
A Modified Bleaching Method for Multiplex Immunofluorescence Staining of FFPE Tissue SectionsDan Wang, Alison Cheung, Gordon E Mawdsley, et al.
The Canadian Journal of Hospital Pharmacy|March 14, 2024
Clinical Pharmacy Services in Canadian Emergency Departments: A 2022 National SurveyRichard Wanbon, Eric Villeneuve, Olena Serwylo, et al.
Molecular and Cellular Biology|August 23, 2002
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent mannerAtsushi Hirao, Alison Cheung, Gordon Duncan, et al.
Cancer Research|October 29, 2021
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune ResponseNisha Kanwar, Zaldy Balde, Ranju Nair, et al.
Pageof 1